Heartbeam (BEAT) vs OptimizeRx (OPRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
OptimizeRx (OPRX) has outperformed Heartbeam (BEAT) over the past year, losing 54.1% versus a loss of 72.9%. OptimizeRx is the larger company by market cap ($157.8 million vs $27.5 million), about 5.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BEAT | OPRX |
|---|---|---|
| Share price | $0.4887 | $8.38 |
| Market cap | $27.54M | $157.85M |
| 1-day change | -10.00% | -1.99% |
| YTD return | -79.64% | -31.65% |
| 1-year return | -72.85% | -54.06% |
| 5-year return | — | -90.10% |
| P/E ratio (TTM) | — | 34.92 |
| Forward P/E | — | 8.03 |
| EPS (TTM) | $-0.50 | $0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.00 | $22.25 |
| 52-week low | $0.355 | $4.54 |
| Distance from 52-week high | -87.78% | -62.34% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +616.19% | +50.36% |
| Average volume | 7.37M | 203.38K |
| Shares outstanding | 56.35M | 18.84M |
| Employees | 16 | 132 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Medical/Dental Instruments | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OptimizeRx is about 5.7 times larger than Heartbeam by market value ($157.85M vs $27.54M).
- OPRX has outperformed BEAT by 18.8 percentage points over the past year.
- The two companies sit in different sectors: Heartbeam in Health Care and OptimizeRx in Consumer Discretionary.
About Heartbeam
BEAT stock →HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
Health Care · Medical/Dental Instruments · 16 employees
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Consumer Discretionary · Business Services · 132 employees
BEAT vs OPRX FAQ
Which is bigger, Heartbeam or OptimizeRx?
OptimizeRx (OPRX) is larger, with a market capitalization of $157.85M compared with $27.54M for Heartbeam (BEAT).
Which stock has performed better over the past year, BEAT or OPRX?
OPRX returned -54.06% over the past 12 months, compared with -72.85% for BEAT (price return, excluding dividends). Past performance does not predict future results.
Are Heartbeam and OptimizeRx in the same industry?
No. Heartbeam is in the Health Care sector, while OptimizeRx is in Consumer Discretionary.